Sutro Biopharma
STRO
STRO
130 hedge funds and large institutions have $216M invested in Sutro Biopharma in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 119 → 130 (+11)
0.95% less ownership
Funds ownership: 77.23% → 76.28% (-0.95%)
Holders
130
Holding in Top 10
–
Calls
$268K
Puts
$121K
Top Buyers
| 1 | +$2.85M | |
| 2 | +$2.51M | |
| 3 | +$2.41M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.21M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.75M |
Top Sellers
| 1 | -$8.06M | |
| 2 | -$5.02M | |
| 3 | -$2.29M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$1.8M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.21M |